Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the... see more

TSX:EDT - Post Discussion

Spectral Medical Inc > Spectral Medical Tigris Trial and Corporate Update Call
View:
Post by TechOne on Dec 14, 2024 2:42am

Spectral Medical Tigris Trial and Corporate Update Call

Spectral Medical Tigris Trial and Corporate Update Call
 

Chris Seto, Chief Executive Officer, and Dr. John Kellum, Chief Medical Officer, will host the call followed by a question-and-answer session. All interested parties are invited to participate.
 

CONFERENCE CALL DETAILS:
 

Date:

Monday, December 16, 2024

 

 

Time:

10:00 a.m. ET

 

 

Dial-in:

1-877-407-0792 or 1-201-689-8263

 

 

https://callme.viavid.com/viavid/?callme=true&passcode=13744665&h=true&info=company&r=true&B=6

 

 

Participants can use Guest dial-in #s above and be answered by an operator OR click the Call me link for instant telephone access to the event. *Available 15 minutes prior to scheduled start time.
 

Replay Dial-in:

1-844-512-2921 or 1-412-317-6671
 

 

Available December 16, 3:00 p.m. ET, until December 30, 11:59 p.m. ET

 

 

Conference ID:

13750410

Comment by daviking on Dec 14, 2024 2:58pm
Speculation on Spectral??? To the moon or nail in the coffin!?  
Comment by oilandgasman on Dec 14, 2024 4:05pm
Someplace in-between  Another hazy timeline with a financing announcement. Half answers with zero hard trial or data information. A half-hearted stab at convincing anyone who buys it still that enrollment is good.   I wouldn’t get my hopes up to much. I usually walk away from these calls with more questions about both the companies resistance to sharing news and the ...more  
Comment by BlueJays9293 on Dec 15, 2024 7:37pm
A delicious pasta, needs less freshly grated cheese, than you think. Otherwise, you miss the Moon, and only get the Cheese. #BruceLee
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities